Propanc Biopharma Inc (PPCB)

[the gipper]

developmental stage biotechs are incubators for future drugs which have the potential to make billions. The regulatory process is long and costly, but each step of the way in the process, potential drugs become increasingly valuable. PPCH is right now completing animal studies, and preparing to initiate Phase I, and later Phase II.
The market for pancreatic cancer, and other types is nothing short of huge. If the current animal studies going on in the US are able to increase the efficacy of PRP we may have BP other BB knocking on the door willing to partner development costs. There are many pathways to market, and ODD can significantly shorten the journey.
BP are cash rich, and many of their patents are expiring, and they are hungry to acquire promising biotechs with good candidates. Propanc may end up being one of those companies. A successful drug can be worth billions..............Risk????of course, but the rewards can be immense!